[go: up one dir, main page]

DK1063990T3 - Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser - Google Patents

Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser

Info

Publication number
DK1063990T3
DK1063990T3 DK99912976T DK99912976T DK1063990T3 DK 1063990 T3 DK1063990 T3 DK 1063990T3 DK 99912976 T DK99912976 T DK 99912976T DK 99912976 T DK99912976 T DK 99912976T DK 1063990 T3 DK1063990 T3 DK 1063990T3
Authority
DK
Denmark
Prior art keywords
biochanine
estrogen
treatment
associated disorders
enriched extract
Prior art date
Application number
DK99912976T
Other languages
English (en)
Inventor
Graham Edmund Kelly
Alan James Husband
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Application granted granted Critical
Publication of DK1063990T3 publication Critical patent/DK1063990T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK99912976T 1998-03-26 1999-03-26 Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser DK1063990T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP2607A AUPP260798A0 (en) 1998-03-26 1998-03-26 Treatment of medical related conditions with isoflavone containing extracts of clover
PCT/AU1999/000222 WO1999048496A1 (en) 1998-03-26 1999-03-26 Therapy of estrogen-associated disorders

Publications (1)

Publication Number Publication Date
DK1063990T3 true DK1063990T3 (da) 2007-05-21

Family

ID=3806868

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99912976T DK1063990T3 (da) 1998-03-26 1999-03-26 Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser

Country Status (16)

Country Link
US (3) US6599536B1 (da)
EP (1) EP1063990B1 (da)
JP (1) JP2002507568A (da)
AU (1) AUPP260798A0 (da)
BR (1) BR9909105A (da)
CA (1) CA2325631A1 (da)
DE (1) DE69934877T2 (da)
DK (1) DK1063990T3 (da)
ES (1) ES2281169T3 (da)
IL (1) IL138129A (da)
NO (1) NO325456B1 (da)
NZ (1) NZ506701A (da)
PT (1) PT1063990E (da)
TR (1) TR200002770T2 (da)
WO (1) WO1999048496A1 (da)
ZA (1) ZA200005070B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023069A1 (en) * 1992-05-19 1993-11-25 Graham Edmund Kelly Health supplements containing phyto-oestrogens, analogues or metabolites thereof
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
CA2287965C (en) * 1997-05-01 2009-10-20 Graham Edmund Kelly Treatment or prevention of menopausal symptoms and osteoporosis
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ008399A0 (en) * 1999-04-28 1999-05-27 Novogen Research Pty Ltd Cariovascular applications
AU761047B2 (en) * 1999-04-28 2003-05-29 Novogen Research Pty Ltd Cardiovascular and bone treatment using isoflavones
US20090233999A1 (en) * 1999-09-06 2009-09-17 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
US20040213859A1 (en) * 1999-09-17 2004-10-28 Zelickson Brian D. Organic nutrient for hair loss treatment
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
EP1174144A1 (en) 2000-07-20 2002-01-23 Linnea S.A. Dry extract rich in isoflavones and process of preparation
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
DE10114305A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Isoflavonen und Verwendung von Isoflavonen zur Herstellung kosmetischer und dermatologischer Zubereitungen zur Reduktion des Sebumgehaltes der Haut
ES2300399T3 (es) * 2002-04-30 2008-06-16 Cognis Ip Management Gmbh Empleo de mezclas de principios activos con acido acelaico y acido glicirretico como agentes anti-acne.
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
BR0313182A (pt) * 2002-07-24 2007-07-24 Childrens Hosp Medical Center composições e produtos contendo equol enantiomérico
US7468445B2 (en) * 2002-08-07 2008-12-23 University Of Mississippi Antigiardial agents and use thereof
CA2504682A1 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
EP2305272A1 (en) * 2004-04-28 2011-04-06 Brigham Young University Use of equol for treating skin diseases
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
EP1842541A1 (en) 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Plant components and extracts and uses thereof
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US10307451B2 (en) * 2010-02-15 2019-06-04 Sinoveda Canada Inc. Phytoestrogen product of red clover and pharmaceutical uses thereof
JP2014169286A (ja) * 2013-02-07 2014-09-18 Shiga Univ Of Medical Science 子宮筋腫に伴う子宮出血抑制用医薬
JP6985656B2 (ja) * 2017-02-28 2021-12-22 ニチモウ株式会社 子宮内膜症改善用組成物およびその製造方法
JP7281156B2 (ja) * 2018-05-16 2023-05-25 共栄化学工業株式会社 皮膚外用剤
CN111838198B (zh) * 2020-08-17 2021-07-02 南通大学 鹰嘴豆提取物在防治农作物病原细菌中的应用
WO2022250488A1 (ko) * 2021-05-28 2022-12-01 연세대학교 산학협력단 난소내막종의 예방 또는 치료용 조성물
WO2024102744A1 (en) * 2022-11-07 2024-05-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Phytoserm formulations for the promotion of cognitive function, sleep quality, and mood symptoms

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2890116A (en) * 1957-10-31 1959-06-09 Emanuel M Bickoff Estrogenic factor
DE1518002C3 (de) 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1543749A1 (de) 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US3973608A (en) 1973-08-01 1976-08-10 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Microbial production of certain isoflavones
HU168753B (da) 1974-05-03 1976-07-28
DE2643800C2 (de) 1976-09-29 1986-10-30 Fritz Werner Industrie-Ausrüstungen GmbH, 6222 Geisenheim Verfahren zur Herstellung von Xylose durch enzymatische Hydrolyse von Xylanen
US4257984A (en) * 1977-04-04 1981-03-24 Henkel Corporation Monotertiarymonosecondarydiprimarytetramine and monotertiarymonosecondarydinitrilodiamines
US4264509A (en) 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
SU907060A1 (ru) 1979-02-07 1982-02-23 Всесоюзный Научно-Исследовательский Биотехнический Институт Способ получени розового масла
US4366082A (en) 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4390559A (en) 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
JPS5933232A (ja) * 1982-08-19 1984-02-23 Tokiwa Kanpou Seiyaku:Kk マメ科植物からサポニン類およびフラボン類の分離方法
JPS59199630A (ja) 1983-04-26 1984-11-12 Takeda Chem Ind Ltd 卵巣機能低下症治療剤
JPS6048924A (ja) 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
JPS6054379A (ja) 1983-09-05 1985-03-28 Takeda Chem Ind Ltd 新規４ｈ−１−ベンゾピラン−４−オン誘導体，その製法および用途
JPS61246124A (ja) 1985-04-24 1986-11-01 Yamanouchi Pharmaceut Co Ltd 制癌剤
JPS62106017A (ja) 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd 抗腫瘍剤
JPS62106016A (ja) 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd 免疫抑制剤
JPS62126186A (ja) 1985-11-28 1987-06-08 Tsumura Juntendo Inc イソフラボン誘導体含有溶液の製造方法
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
JPS6442427A (en) 1987-08-10 1989-02-14 Tsumura & Co Sialidase inhibitor
JPH0714927B2 (ja) 1988-04-06 1995-02-22 キッコーマン株式会社 イソフラボン化合物の製造法
JPH0267218A (ja) 1988-08-31 1990-03-07 Nagakura Seiyaku Kk ウイルス・ゲノム不活化剤
JPH0269165A (ja) 1988-09-02 1990-03-08 Mitsugi Ohashi 癌抑制食品
JP2753719B2 (ja) 1988-12-15 1998-05-20 日本油脂株式会社 リポソーム製剤の製造法
JPH0347049A (ja) 1989-03-09 1991-02-28 Sanyu:Kk 豆腐廃液ゆからの食品素材及び健康飲料の製造方法
US5153230A (en) * 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
CH679584A5 (da) 1989-11-10 1992-03-13 Nestle Sa
DE69006502T2 (de) * 1990-04-06 1994-05-19 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., Budapest Verbessertes verfahren zur darstellung substituierter isoflavonderivate.
GB2261671B (en) 1991-11-16 1996-07-03 Gb Biotech Gel production from plant matter
WO1993023069A1 (en) * 1992-05-19 1993-11-25 Graham Edmund Kelly Health supplements containing phyto-oestrogens, analogues or metabolites thereof
AU6635994A (en) * 1993-04-16 1994-11-08 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
JP3787844B2 (ja) 1993-10-12 2006-06-21 アーチャー ダニエルズ ミッドランド カンパニー アグルコンイソフラボン濃縮植物タンパク質乳漿，乳漿タンパク質，及びその製造方法
US5320949A (en) 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
BR9407792A (pt) 1993-10-12 1997-03-18 Protein Tech Int Processo para produção de um extrato enriquecido com isoflavona de aglucona de um material de proteina vegetal extrato enriquecido com isoflavona de aglucona isolado de proteina enriquecido com isoflavona de aglucona isolado de proteina vegetal e processo para recuperação de pelo menos 50% de uma isoflavona de um material de proteina vegetal
IL112061A (en) 1994-01-13 1999-10-28 Bristol Myers Squibb Co Methods for the preparation of taxanes
US5506211A (en) 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5424331A (en) 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5547866A (en) 1994-07-20 1996-08-20 The Regents Of The University Of California Taxane production in haploid-derived cell cultures
DE4432947C2 (de) * 1994-09-16 1998-04-09 New Standard Gmbh Mittel zur Behandlung der Haut und seine Verwendung
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5679806A (en) 1995-02-24 1997-10-21 Hauser, Inc. Process for the isolation and purification of isoflavones
JPH08283283A (ja) 1995-04-14 1996-10-29 Kikkoman Corp マロニルイソフラボン配糖体及び該物質からイソフラボン配糖体又はイソフラボンアグリコンを取得する方法
US5639785A (en) * 1995-06-07 1997-06-17 Global Pharma, Ltd. Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
US6033714A (en) * 1996-03-13 2000-03-07 Archer Daniels Midland Company Process for production of isoflavone fractions from soy
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
AU731951B2 (en) * 1996-08-30 2001-04-05 Novogen Research Pty Ltd Therapeutic methods and compositions involving isoflavones
US5726034A (en) 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
US5804234A (en) * 1996-09-13 1998-09-08 Suh; John D. Plant protein for nutritional products and method of making same
US5733926A (en) 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
AUPO644897A0 (en) 1997-04-28 1997-05-22 Novogen Inc Preparation of isoflavones from legumes
WO1998048790A1 (en) 1997-04-28 1998-11-05 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
CA2287965C (en) 1997-05-01 2009-10-20 Graham Edmund Kelly Treatment or prevention of menopausal symptoms and osteoporosis
US6083526A (en) 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US5942539A (en) 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
FR2769502B1 (fr) * 1997-10-14 2000-04-14 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir du trefle (trifolium sp.)
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
US6004558A (en) 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
FR2781154B1 (fr) 1998-07-15 2001-09-07 Lafon Labor Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
US20040072765A1 (en) * 1999-04-28 2004-04-15 Novogen Research Pty Ltd. Cardiovascular and bone treatment using isoflavones
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same

Also Published As

Publication number Publication date
PT1063990E (pt) 2007-04-30
BR9909105A (pt) 2000-12-05
NO20004688D0 (no) 2000-09-19
AUPP260798A0 (en) 1998-04-23
IL138129A0 (en) 2001-10-31
DE69934877D1 (de) 2007-03-08
WO1999048496A1 (en) 1999-09-30
EP1063990A1 (en) 2001-01-03
TR200002770T2 (tr) 2000-11-21
EP1063990B1 (en) 2007-01-17
US6599536B1 (en) 2003-07-29
IL138129A (en) 2005-06-19
CA2325631A1 (en) 1999-09-30
US20080038387A1 (en) 2008-02-14
NZ506701A (en) 2003-07-25
ES2281169T3 (es) 2007-09-16
JP2002507568A (ja) 2002-03-12
ZA200005070B (en) 2001-12-21
NO20004688L (no) 2000-09-19
EP1063990A4 (en) 2003-01-02
US20030219499A1 (en) 2003-11-27
DE69934877T2 (de) 2007-11-08
NO325456B1 (no) 2008-05-05

Similar Documents

Publication Publication Date Title
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK0967214T3 (da) Intranasale formuleringer til behandling af seksuelle forstyrrelser
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1223927T3 (da) Anvendelse af retigabin til behandling af neuropatiske smerter
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DK2412368T3 (da) Sammensætning til behandling af ar
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1292594T3 (da) Quinazolinderivater til behandling af tumorer
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK199800837A (da) Anlæg til behandling af emner
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
DK0928183T3 (da) Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser